SCHEMBL8309657

SCHEMBL8309657

C/C(=N/OCCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 12/20 0.76
FFAR1 O14842 8/20 0.61
MPC2 O95563 1/20 0.54
CYP2C8 P10632 1/20 0.54
CYP2C9 P11712 1/20 0.54
MAPT P10636 2/20 0.53
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
TP53 P04637 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
HPGD P15428 1/20 0.53
ALOX15 P16050 1/20 0.53
TSHR P16473 1/20 0.53
KMT2A Q03164 1/20 0.53
HSD17B10 Q99714 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
PPARA Q07869 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8309658 1.00 PPARG (0.76) PPARGFFAR1MPC2CYP2C8CYP2C9
SCHEMBL6898656 0.94 PPARG (0.81) PPARGFFAR1MPC2CYP2C8CYP2C9
SCHEMBL6899309 0.94 PPARG (0.81) PPARGFFAR1MPC2CYP2C8CYP2C9
SCHEMBL8305134 0.91 PPARG (0.74) PPARGFFAR1MPC2CYP2C8CYP2C9
SCHEMBL8305047 0.91 PPARG (0.71) PPARGFFAR1MPC2CYP2C8CYP2C9
SCHEMBL8305132 0.91 PPARG (0.74) PPARGFFAR1MPC2CYP2C8CYP2C9
SCHEMBL8305046 0.91 PPARG (0.71) PPARGFFAR1MPC2CYP2C8CYP2C9
SCHEMBL8306378 0.91 PPARG (0.69) PPARGFFAR1MPC2CYP2C8CYP2C9
SCHEMBL8306376 0.91 PPARG (0.69) PPARGFFAR1MPC2CYP2C8CYP2C9
SCHEMBL8309044 0.91 PPARG (0.69) PPARGFFAR1MPC2CYP2C8CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed